Нашему интернет–форуму нужны активные и внимательные участники для поддержания порядка и чистоты обсуждений. Если вам интересно следить за развитием ресурса и помогать пользователям - Ждем вас в нашей команде! 
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long term safety data are still limited, and side effects such as nausea are common.
Source: https://www.sciencedaily.com/releases/2 ... 073033.htm
Source: https://www.sciencedaily.com/releases/2 ... 073033.htm
